Ziakas A, Gavrilidis S, Parisiadou A, Parxaridis G
1st Department of Cardiology, AHEPA University Hospital, Thessaloniki, Greece.
Minerva Cardioangiol. 2007 Dec;55(6):839-43.
Stenting of symptomatic myocardial bridges is a therapeutic option with documented good short-term outcome. However, limited data on the long term outcome of myocardial bridge stenting has shown a higher restenosis rate comparing to stenting of de novo atherosclerotic lesions. Drug-eluting stenting of de novo atherosclerotic lesions has reduced the rate of restenosis comparing to bare metal stenting, but there is no available data on drug-eluting myocardial bridge stenting. We present a case of accelerated in-stent restenosis after bare-metal myocardial bridge stenting, successfully treated with drug-eluting stenting.
对有症状的心肌桥进行支架置入术是一种已被证明短期效果良好的治疗选择。然而，关于心肌桥支架置入术长期效果的有限数据显示，与初发动脉粥样硬化病变的支架置入术相比，其再狭窄率更高。与裸金属支架置入术相比，初发动脉粥样硬化病变的药物洗脱支架置入术降低了再狭窄率，但尚无关于药物洗脱心肌桥支架置入术的可用数据。我们报告一例裸金属心肌桥支架置入术后支架内再狭窄加速的病例，经药物洗脱支架置入术成功治疗。
